OSR Holdings enters term sheet to acquire Woori IO for noninvasive glucose monitoring tech

OSR Holdings, Inc.

Non-binding term sheet: OSRK to acquire WORIO via share exchange; WORIO shareholders receive OSRK shares convertible into OSRH common stock.
Conversion conditional on OSRH stock reaching $10.00 within 3 years; fixed ratio 1 OSRK = 12.96 OSRH shares.
6-month exclusivity period for due diligence; parties aim to complete transaction within that period.
WORIO's platform uses near-infrared spectroscopy (NIRS) for noninvasive glucose monitoring; completed proof-of-concept with Korea University Hospital.
Glucose monitoring devices market projected to exceed $40B by 2030; WORIO selected by Samsung C-Lab Outside in Q1 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.